Analysis of efficacy and safety for the combination of regorafenib and PD-1 inhibitor in advanced hepatocellular carcinoma: A real-world clinical study
Article in iLiver (June 2024)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Article in iLiver (June 2024)
Article in Journal of Gastrointestinal Oncology (April 2024)
Article in International Immunopharmacology (March 2024)